Derm-Biome Pharmaceuticals

Derm-Biome Pharmaceuticals is a preclinical biopharmaceutical company established in 2018 through the acquisition of a set of derivatives based on natural compounds. These compounds exhibit potent anti-inflammatory, antibacterial, antitumor, and antioxidant properties and have demonstrated significant inhibitory effects in well-established mouse models of atopic dermatitis and psoriasis, halting the progression of these diseases in a dose-dependent manner.